Related:FDA Approves Roche’s Polivy Combo Therapy For Untreated Patients With Diffuse Large B-Cell Lymphoma. The Diagnostics Division base business grows 4%, while divisional sale …
Read Full Story at source (may require registration)
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024
- FTSE 100 Modestly Higher In Cautious Trade - November 27, 2024
- CAC 40 Slides As French Risk Premium Peaks - November 27, 2024